Hollywood Hunter

Simon turned a page of the material in his hand, and his face rubbed against Janet’s head, saying, "The medical industry is not as stable as other industries such as energy and telecommunications, because human society not only always has various The emergence of such new diseases, the overall development and transformation of this industry is also much faster than that of energy and telecommunications. No medical giant can survive with one or two drugs or technologies. This is our opportunity."

Janet hummed her head. She was just comfortable with Simon's rubbing, but she came over a little bit. She was not very interested in this issue. She was tired of helping Simon watching Cersei Capital on weekdays. More, just asked in the tone of the man: "So what are you going to do with it?"

Simon felt Janet sticking around and hugged the woman's waist, saying, "Looking at the information recently, I have had a lot of ideas. However, I found that these methods are in conflict with my conscience, and it is a test of the moral bottom line. ."

Janet didn't care, but instead looked curious: "Say one."

Simon said: "For example, a large number of orphan drug manufacturers or product patents with a small market demand are acquired, monopolizing this market, and then directly raising the price by 10,000 times."

Janet blinked and didn't quite understand Simon's term "orphan drug".However, according to the description of "the market demand is small", it is roughly understood what it is.With the help of a woman's brain, she quickly sorted out the joints.

If this can really be done, then the benefits will be a bit mad.

Thinking about it like this, Janet could also feel that Simon had no expectation in his tone when he said this, but instead had a trace of sarcasm.Detective touched his man's face, Janet said: "I think governments of all countries should not allow this to happen?"

Simon turned his head and kissed gently in the palm of the woman, saying, "Maybe not before, but not necessarily afterwards?"

"Ok?"

"This is related to the development trend of the federal medical industry," Simon said, looking down at Janet with curiosity, knowing that she was actually not that interested, smiling, or saying: "According to the information I have seen recently, the federal The medical industry has begun to show the same integration trend as the media industry. At this stage, dozens of large and small pharmaceutical companies in the United States may have only a few giants like the media industry in the future. By then, these powerful pharmaceutical giants With the lobbying capacity of the government authorities and its own resource monopoly capacity, it can be very easy to promote the plan I just mentioned."

The integration of pharmaceutical giants is a major trend discovered by Simon during the recent study of the US medical industry.

Combined with the information in my mind, the whole vein is clearer.

Just like the United States in memory is Ruihui, the world's largest pharmaceutical oligarch, although it is also an industry giant at this stage, its strength in the US medical industry is not outstanding.Ruihui formed its market position after several large-scale mergers and acquisitions in the 1990s.

There is one more interesting thing.

The turning point of Ruihui's industry status was probably in memory in 1997. This year, Ruihui launched the later world-famous'Van Aike'. This kind of blue pill that can sell hundreds of tablets per minute seems to also Added a dose of stimulant to Ruihui.

The appearance of Simon's big butterfly changed many things, but some things haven't changed.

For example, the progress of the small blue pills.

And, the wave of new technology.

The wave of new technology in the United States in the 1990s covered not only the Internet, but also fields such as genetic science and biopharmaceuticals. This also led to the rapid rise in the market value of the pharmaceutical industry that also developed various new technology concepts in the late 1990s.

Now, because Simon promoted the outbreak of the Internet industry in advance, the current wave of new technology is almost equal to the Internet wave.

For investment in fields such as genetic science and biopharmaceuticals, it was still in the past year because of excess funds in the Internet industry.

Simon chose to enter the US medical industry at this point in time. In fact, it is also the beginning of the medical industry's rapid market value and large-scale integration. Entering the market at this time is equivalent to a bottoming out.

Take Ruihui for example.

The current market value of Ruihui is about US$27 billion.Simon remembered that the peak of the Internet bubble, Ruihui's market value once broke through 200 billion US dollars.Perhaps this is due to Ruihui's massive merger with other companies, but entering the market at this time is just buying Ruihui's stock. Even if the new technology bubble bursts in the next few years, as long as the integration trend of the medical industry has not changed, it will be enough Generous profits.

Under the eaves of a Tasmanian manor house.

Janet leaning in Simon's arms finished listening to the man, paused for a moment, and said, "Honey, if you think, um... boring, then we won't be involved."

"Of course not," Simon refused quickly, bowed his head and kissed on Janet's lips, said: "You know, I'm not used to being a crushed person in the food chain, since the rules are the same, the trend is the same, then I’m going up to occupy a most advantageous position for myself."

Janet is good at her: "Well."

It's very small.

Simon smiled and squeezed the woman's smooth face: "Okay, don't say these boring things, what do you want to eat at night?"

Janet immediately got interested: "The weather is so good today, so I can barbecue outdoors later."

Simon simply stood up and held up the woman's body: "Then we will prepare together. It is better to arrange this kind of thing by hand."

Continue to spend the weekend in Tasmania, the family returned to Melbourne for a few days, and eventually returned to North America, the time is already January 15.

After a period of time and consideration, Simon returned to North America and soon began to deploy the Westeros system in the US medical industry.

The first is the simplest stock buying operation.

Simon discussed with Jeremy’s father, James Rebold, who was in charge of Westeros, and decided to use the nearly US$2 billion of funds obtained from cashing in Daenerys Entertainment’s stock to buy several major US companies such as Ruihui. Pharmaceutical giant stocks.

Not only that, the Black Rock Asset Management Company under Cersei Capital will also quietly enter the market.

This time it is still a common 4.9% plan.

Just buying 4.9% of the stock of Ruihui and other companies just does not need to report, and if you need it in the future, you can also cash out at any time.

On the other hand, Apollo Management will set up a merger and acquisition consulting team for pharmaceutical companies and initiate special targeted fund financing, so that it can take a slice of the wave of medical industry integration in the next few years.

At the same time, the political lobbying team of the Westeros family also began to pay close attention to the various policies of the Washington authorities related to the medical industry.

Multiple strategies go hand in hand.

Simon's plan is that in the next five years, the Westeros system will successfully penetrate all aspects of the American medical industry system and have considerable voice.

This is also Simon's final plan.

After reviewing a large number of industry inside information that ordinary people can never see during Australia, Simon realized that in the field of medical industry, the Westero system is the wisest choice to stand behind the scenes. After all, this field should be viewed by ordinary people. The operation of hell is endless.

Just like the'orphan drug' monopoly strategy.

Simon's plan with Janet when he was in Australia was actually what the major US medical giants were doing in memory, and even formed a wave.

As a result, many rare disease medicines with very small demand in the market often cost just a few years, and the price has skyrocketed from a few dollars a box to a few thousand dollars or even tens of thousands of dollars.

If it was before the 1990s, this kind of thing is unlikely to happen.

Because at that time, the number of large pharmaceutical companies in the United States was still very large and competition was fierce.Moreover, after the introduction of the "Orphan Drug Act" in 1983, the traditional medical giants did not value this field at first. Basically, many small companies trying to overtake in the corner were sitting.

After the small start-up companies developed the corresponding drugs, the prices initially introduced to the market were quite cheap because of constraints such as bargaining power, government control, and even their own morality.

After the 1990s, the integration of the US medical industry was completed, Ruihui and other pharmaceutical oligarchs rose, and they finally noticed that the orphan drug companies and patents scattered around the market like pearls began large-scale Internet acquisitions. Then, according to their own industries The influence will soon increase the price by hundreds, thousands, or even tens of thousands of times.

Unlike those small enterprises, the oligarchs of the pharmaceutical industry not only have strong bargaining power and monopoly power, but also have a very strong right to speak at all levels of government. The price increase is completely fearless, and even excessive government intervention will affect pharmaceutical companies. Reasons such as the enthusiasm for research and development of rare diseases require the authorities to formulate a bill to relax price control in this area.

As a result, the once-vigorous development of the orphan drug industry not only quickly changed from cheap drugs to sky-high drugs, but also under the monopoly of pharmaceutical oligarchs, the market threshold increased significantly, and even the U.S. government deliberately pushed the orphan drug review threshold to 80 When the "Orphan Drug Act" was first launched, the state of blooming flowers soon ceased, but it became a private reserve after the profits of various pharmaceutical giants.

Later, many patients who could not afford high-priced orphan drugs filed large-scale lawsuits against medical giants, and the results basically ended in failure.

So much so that when arranging the Westeros system to enter the medical industry, the sentence in Marx's "Capital" will always appear in Simon's mind.

Capital came to earth with sin.

However, Simon didn't go into the field because Janet said "not interesting".

In the world of weak meat and strong food, the fat that is readily available is not going to be hunted. The trade-offs will only result in becoming weaker and weaker.

In addition to these general layouts, according to the data read during Australia and the sorting out of the information in memory, Simon also made some small-scale moves.

For example, a company called Gilead in San Francisco.

Gilead, founded in 1987, did nothing until the beginning of 1996, basically nothing.

According to the status quo at this time and the information in memory, Simon roughly pieced together the trajectory of this enterprise known as the "Apple" of the pharmaceutical industry.

The key to Gilead's success is actually a person.

Donald Rumsfeld.

The politician who served as the US Secretary of Defense for two consecutive years in 1975 and 2001 for more than 20 years, is currently a member of Gilead's board of directors.

In memory, Rumsfeld will be the chairman of Gilead in 1997 and will be in charge of the company.

Then, in 2001, Rumsfeld left office and began to serve as the defense minister of the Bush administration. Gilead also began to take off, relying on the treatment of hepatitis C drugs to become the "Apple" of the pharmaceutical industry.

Ordinary people can only see four characters through these contexts, and the benefits are conveyed.

It's just how to litigate, and most people obviously have no idea.

Simon knew it.

The most important step of Gilead is not the acquisition of a pharmaceutical company that has developed a treatment for hepatitis C, but this product, which successfully penetrated the US medical insurance system at a high price!

If someone understands Gilead's hepatitis C drugs, they will find that the cost of a course of related drugs is nearly 80,000 US dollars, some of which will be sold for 1,000 US dollars.At such a high price, ordinary Americans simply cannot afford it.

Under normal circumstances, if Gilead maintains such a high price, it will only become a niche drug, and the treatment target is limited to the rich.

In this way, it is impossible to obtain too high revenue.

However, what is very unexpected is that while keeping high prices for its own hepatitis C drugs, Gilead miraculously entered the US medical insurance system.

Now, the sky-high price of $80,000 for a course of treatment is basically paid by the US government and insurance companies. As long as the average American has health insurance and has Hepatitis C, he does not need to spend much money. The US government and insurance companies pay for it.

Americans seem to think that they will not suffer losses, but where does the money from the US government and insurance companies come from?

It will never fall from the sky.

This seems to be very beneficial to patients, but it is actually the source of the abnormally high medical cost in the United States.

As for the interests involved, it is clear at a glance.

Now that the layout has been determined, Simon certainly will not let this company go, and plans to advance a former defense minister who is still a member of the board of directors to the position of chairman.

Outside of Gilead, Simon did not forget China.

The layout there is mainly two aspects, Chinese medicine, and health products.

Simon plans to set up some startups in China that specialize in studying the feasibility of batching traditional Chinese medicine.The accumulation of Chinese medicine for thousands of years is actually a potential gold mine.

In addition, the most important thing is actually investment in the field of health products.

It just so happens that there is a very good opportunity.

A guy in the Zhuhai building is about to go bankrupt because of a broken capital chain, which happens to be a very suitable support object.